Sherlock Biosciences is a diagnostics company using CRISPR and synthetic biology platforms to provide at-home molecular testing solutions.
Sherlock Biosciences, founded by Catalio Venture Partner Dr. Jim Collins, has engineered two pioneering technology platforms, called INSPECTR and SHERLOCK, that deliver diagnostic tests with the accuracy of PCR and the convenience and simplicity of antigen tests. By using CRISPR enzymes and synthetic biology, Sherlock’s products can detect DNA and RNA associated with a huge range of diseases. The simplicity of their products means tests can be done at home as well as in a low resource setting, and without the need for specialist knowledge or equipment to process samples or interpret results. Sherlock made history in 2020 when one of its products became the first FDA-authorized use of CRISPR technology; the company is positioned to transform the quality and patient experience of at-home diagnostics.
Location: United States, Massachusetts, Boston
Total raised: $146M
Investors 1
| Date | Name | Website |
| - | Catalio Ca... | cataliocap... |
Funding Rounds 3
| Date | Series | Amount | Investors |
| 10.03.2022 | Series B | $80M | - |
| 23.04.2019 | Series A | $31M | - |
| 21.03.2019 | - | $35M | - |
Mentions in press and media 17
| Date | Title | Description | Source |
| 13.07.2023 | Diagnostic Testing Landscape Paves the Way for Consumer Cent... | The diagnostics sector has benefited from a few trends in the past five years that not only have the... | medcitynew... |
| 10.03.2022 | Sherlock Biosciences Scores $80M in Series B | BOSTON, MA, Sherlock Biosciences, a company engineering biology, has raised $80 million in a Serie... | vcnewsdail... |
| 08.03.2022 | Sherlock Biosciences Raises $80M in Series B Funding | Sherlock Biosciences, a Boston, MA-based biology diagnostics company, raised $80M in Series B fundin... | finsmes.co... |
| 08.03.2022 | Sherlock Biosciences Raises $80 Million in Series B Financin... | - | novalislif... |
| 08.03.2022 | Sherlock Biosciences raises $80M Series B for at-home diagno... | Sherlock Biosciences announced today that it raised $80 million in a Series B financing round to sup... | massdevice... |
| 03.03.2021 | CRISPR rivals put patents aside to help in fight against Cov... | In early January 2020, Feng Zhang, a gene-editing researcher at the Broad Institute of MIT and Harva... | statnews.c... |
| 10.06.2020 | How CRISPR research in Delaware can fight both COVID-19 and ... | In March, Dr. Eric Kmiec, director of ChristianaCare’s Gene Editing Institute (GEI), and Dr. Jonatha... | technical.... |
| 08.05.2020 | FDA Approves CRISPR-Based Coronavirus Test | Public health officials universally agree that the world needs much more coronavirus testing before ... | extremetec... |
| 24.01.2020 | DNA sleuths read the coronavirus genome, tracing its origins... | As infectious disease specialists and epidemiologists race to contain the outbreak of the novel coro... | statnews.c... |
| 24.04.2019 | Daily funding roundup - April 24th, 2019 | Motimatic raised $4M; Vital secured $5.2M; Credly closed $11.1M; Vue.ai landed $17M Chili Piper: Ch... | vator.tv/n... |
Show more